PubRank

The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity (CIDO OEA)

Clinical Trial ID NCT01976156

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01976156

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008 4.94
2 Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999 2.90
3 The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998 2.88
4 Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991 2.30
5 D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997 2.28
6 D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 2003 1.95
7 Weight gain is associated with reduced striatal response to palatable food. J Neurosci 2010 1.94
8 Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 2003 1.88
9 Youth at risk for obesity show greater activation of striatal and somatosensory regions to food. J Neurosci 2011 1.84
10 Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. Br J Nutr 2008 0.80
11 The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: a double-blind, randomized control trial. Lipids Health Dis 2012 0.78
Next 100